Discover the detailed record of transactions filed by McKenzie Kathryn B, Chief Financial Officer. Insider active across 1 companies, notably Neogenomics INC. Cumulatively, 6 disclosures have been recorded. Total volume traded: €115k. The latest transaction was filed on 11 January 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
6 of 6 declarations
Kathryn B. McKenzie is the Chief Financial Officer and Chief Sustainability/Risk Officer at NEOGENOMICS INC. She is responsible for the company's financial management, including financial planning and performance analysis. McKenzie plays a key role in optimizing financial resources and NEOGENOMICS' growth strategy. Her expertise in finance and sustainability is essential for the company.